BofA Securities analyst Adam ROn lowered the price target on Astrana Health, Inc (NASDAQ: ASTH) to $49.00 (from $55.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Astrana Health, Inc (ASTH) PT Lowered to $40 at TD CowenMarch 3, 2025 11:47 AM Truist Reiterates Buy Rating on Astrana Health, Inc (ASTH) Following Conference CallMarch 3, 2025 10:33 AM Form 8-K Astrana Health, Inc. For: Mar 03March 3, 2025 8:01 AM Astrana Health, Inc (ASTH) PT Lowered to $50 at BairdMarch 3, 2025 7:09 AM Astrana Health, Inc (ASTH) PT Lowered to $50 at StifelFebruary 28, 2025 7:45 AM ASTH (ASTH) Misses Q4 EPS by 25c ; Offers GuidanceFebruary 27, 2025 4:43 PM Form NT 10-K Astrana Health, Inc. For: Dec 31February 27, 2025 4:35 PM Form 8-K Astrana Health, Inc. For: Feb 27February 27, 2025 4:34 PM Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 ResultsFebruary 27, 2025 4:27 PM Form 8-K Astrana Health, Inc. For: Feb 26February 27, 2025 4:11 PM